2-(Chloromethyl)-1-phenyl-1H-benzo[d]imidazole

Catalog No. :
ACXWSV625
CAS No. :
94937-86-7
Molecular Formula :
C14H11ClN2
Molecular Weight :
242.71

IUPAC Name:2-(chloromethyl)-1-phenyl-1H-benzo[d]imidazole

2-(Chloromethyl)-1-phenyl-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$131.00Login to see priceIn stockInquiry
5g97%$343.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Chloromethyl)-1-phenyl-1H-benzo[d]imidazole
IUPAC Name2-(chloromethyl)-1-phenyl-1H-benzo[d]imidazole
MDL No.MFCD04114570
Molecular FormulaC14H11ClN2
Molecular Weight242.71
SMILESClCC1=NC2=CC=CC=C2N1C3=CC=CC=C3
InChI KeyTYOBCMJTBPLYGR-UHFFFAOYSA-N
Synonym2-CHLOROMETHYL-1-PHENYL-1H-BENZOIMIDAZOLE;2-(CHLOROMETHYL)-1-PHENYL-1H-BENZIMIDAZOLE;1H-Benzimidazole, 2-(chloromethyl)-1-phenyl-;2-(ChloroMethyl)-1-phenyl-1H-benzo[d]iMidazole;2-(chloromethyl)-1-phenylbenzimidazole
CAS No.94937-86-7
PubChem CID20251896

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACXWSV625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACXWSV625 route product structure diagram
    ACXWSV62594937-86-7 In Stock
Inquiry

2. ACXWSV625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCFJP475 route compound structure diagram
    ACCFJP475534-85-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWSV625 route product structure diagram
    ACXWSV62594937-86-7 In Stock
Inquiry

Comments (0)